LTBP3 Gene - Latent Transforming Growth Factor Beta Binding Protein 3

Comprehensive genomic and functional analysis of LTBP3, a key regulator of TGF-β bioavailability and extracellular matrix assembly.

Gene Information Card

Symbol LTBP3
Full Name Latent transforming growth factor beta binding protein 3
Gene Type Protein coding
Chromosomal Location 11q13.1
NCBI Gene ID 4054 ncbi.nlm.nih.gov/gene/4054
Ensembl ID ENSG00000111145
UniProt ID Q9NS15
OMIM ID 602090
HGNC ID 6716
Aliases LTBP-3, LTBP3_HUMAN

Description

LTBP3 encodes latent transforming growth factor beta binding protein 3, a member of the LTBP family. This protein binds to the latent form of TGF-β and targets it to the extracellular matrix, regulating TGF-β activation and bioavailability. LTBP3 is essential for proper skeletal and dental development, as well as for maintaining extracellular matrix integrity. Mutations in LTBP3 are associated with autosomal recessive disorders including dental anomalies and short stature.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Dental anomalies and short stature (DASS) Loss-of-function mutations in LTBP3 disrupt TGF-β sequestration and activation, impairing craniofacial and skeletal development. OMIM #601216; PMID: 25913036
Brachyolmia type 3 (with amelogenesis imperfecta) LTBP3 mutations reduce TGF-β signaling in chondrocytes and odontoblasts, leading to short trunk, short stature, and enamel defects. OMIM #601216; PMID: 25913036
Geleophysic dysplasia 3 LTBP3 deficiency alters extracellular matrix composition and TGF-β latency, contributing to acromelic dysplasia. OMIM #617809; PMID: 27531015

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.5 Medium
Lung 10.2 Medium
Kidney 8.9 Medium
Liver 6.1 Low
Brain 4.3 Low
Testis 15.7 High
Cell Line Expression
Cell Line nTPM Notes
HepG2 9.8 Hepatocellular carcinoma
A549 7.4 Lung adenocarcinoma
MCF7 5.2 Breast adenocarcinoma
HEK 293 11.3 Embryonic kidney
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1240C>T (p.Arg414*) Nonsense Rare Loss of function; premature termination
c.1633G>A (p.Gly545Arg) Missense Rare Impaired protein folding and secretion
c.2056_2057del (p.Leu686fs) Frameshift Rare Loss of function; truncated protein
Mutation functional classification

Loss of Function (LOF)

Most LTBP3 disease-associated mutations are loss-of-function, leading to reduced TGF-β binding and extracellular matrix defects.

Gain of Function (GOF)

No gain-of-function mutations reported in LTBP3.

Dominant Negative (DN)

No dominant-negative mutations reported; LTBP3 disorders are autosomal recessive.

Pathways

TGF-beta signaling pathway (KEGG hsa04350)
Extracellular matrix organization (Reactome R-HSA-1474244)
Regulation of TGF-β activation (Reactome R-HSA-2129379)

Protein Summary

LTBP3 is a 1303-amino-acid extracellular matrix protein that binds latent TGF-β via its latent TGF-β binding domain. It contains multiple EGF-like domains and a hybrid motif that mediates interaction with fibrillin microfibrils. LTBP3 is critical for targeting latent TGF-β to the matrix, where proteolytic release activates TGF-β signaling. Defects in LTBP3 cause skeletal and dental dysplasias due to impaired TGF-β bioavailability.

Related Products

Product name Cat.No. Species Gene ID
LTBP3 Knockout HEK293 Cell Line EDJ-KQ2270 Human 4054 Details Get a Quote
LTBP3 Knockout A-549 Cell Line EDJ-KQ22610 Human 4054 Details Get a Quote
LTBP3 Knockout HCT 116 Cell Line EDJ-KQ22611 Human 4054 Details Get a Quote
LTBP3 Knockout HeLa Cell Line EDJ-KQ22612 Human 4054 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: